On Tuesday, Stantec earned an upgrade to its Relative Strength (RS) Rating, from 68 to 74.
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the top-performing stocks tend to have an RS Rating north of 80 in the early stages of their moves. See if Stantec can continue to rebound and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
While the stock is not near an ideal buy point right now, see if it is able to form and break out from a proper base.
Stantec saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 14% to 35%. Revenue rose from 16% to 19%.
Stantec holds the No. 2 rank among its peers in the Commercial Services-Consulting industry group. Huron Consulting Group is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
